SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR THE SALVAGE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Steinberg, Ryan
Thomas, Lewis
O'Donnell, Michael
Nepple, Kenneth
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.1142
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP26-20
引用
收藏
页码：E301 / E301
页数：1
相关论文
共 50 条
  • [1] Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    Nepple, Kenneth G.
    BLADDER CANCER, 2015, 1 (01) : 65 - 72
  • [2] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Velaer, Kyla N.
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    Nepple, Kenneth G.
    CURRENT UROLOGY REPORTS, 2016, 17 (05)
  • [3] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Kyla N. Velaer
    Ryan L. Steinberg
    Lewis J. Thomas
    Michael A. O’Donnell
    Kenneth G. Nepple
    Current Urology Reports, 2016, 17
  • [4] Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
    Milbar, Niv
    Kates, Max
    Chappidi, Meera R.
    Pederzoli, Filippo
    Yoshida, Takahiro
    Sankin, Alexander
    Pierorazio, Phillip M.
    Schoenberg, Mark P.
    Bivalacqua, Trinity J.
    BLADDER CANCER, 2017, 3 (04) : 293 - 303
  • [5] Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer
    Chakra, Mohamad Abou
    Mcelree, Ian M.
    Packiam, Vignesh T.
    Mott, Sarah L.
    O'Donnell, Michael A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 289e13 - 289e21
  • [6] Sequential intravesical gemcitabine and docetaxel in the treatment of BCG-naive patients with non-muscle invasive bladder cancer.
    Thomas, Lewis
    Steinberg, Ryan
    Nepple, Kenneth Gerard
    O'Donnell, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [7] Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer
    Chevuru, Phani T.
    McElree, Ian M.
    Mott, Sarah L.
    Steinberg, Ryan L.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (03) : 148.e1 - 148.e7
  • [8] Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder Cancer
    McElree, Ian M.
    Packiam, Vignesh T.
    Steinberg, Ryan L.
    Mott, Sarah L.
    Gellhaus, Paul T.
    Nepple, Kenneth G.
    O'Donnell, Michael A.
    JOURNAL OF UROLOGY, 2022, 208 (05): : 969 - 977
  • [9] Intravesical gemcitabine for non-muscle invasive bladder cancer
    Han, Mi Ah
    Maisch, Philipp
    Jung, Jae Hung
    Hwang, Jun Eul
    Narayan, Vikram
    Cleves, Anne
    Hwang, Eu Chang
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (06):
  • [10] Intravesical gemcitabine for non-muscle invasive bladder cancer
    Jones, Gabriel
    Cleves, Anne
    Wilt, Timothy J.
    Mason, Malcolm
    Kynaston, Howard G.
    Shelley, Mike
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):
12345